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Abstract 
POEMS syndrome is a rare multi-system disease with typical features of polyneuropathy, 
organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder and skin changes. 
We describe a 44 year-old woman with polyneuropathy, hepatomegaly, IgA lambda-
plasmacytoma, thrombocytosis, papilledema with elevated protein levels in cerebrospinal 
fluid and multiple cutaneous hemangiomas who was diagnosed with three intracranial lesions. 
Histology revealed capillary hemangiomas, one of them displaying partially glomeruloid 
features. 
 
Keywords 
POEMS syndrome, Crow-Fukase syndrome, polyneuropathy, hemangioma, vascular 
endothelial growth factor 
 
Introduction 
POEMS syndrome is a rare multi-system disease, the acronym POEMS (polyneuropathy, 
organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes) 
characterizes several dominant findings [9]. For the diagnosis, polyneuropathy and 
monoclonal plasma cell disorder have to be present; at least one other major (sclerotic bone 
lesions, Castleman disease, vascular endothelial growth factor (VEGF) elevation) and one 
minor criterion (organomegaly, edema, endocrinopathy, skin changes, papilledema, 
thrombocytosis/polycythemia) is required [4]. Therapeutic strategies include irradiation, 
alkylator-based therapies, corticosteroids and other immune-modulatory drugs as well as 
high-dose chemotherapy with peripheral blood stem cell transplantation [5]. The criterion of 
skin changes includes hyperpigmentation, acrocyanosis, skin thickening and multiple 
hemangiomas. Here, we report the first case of a POEMS syndrome patient with intracranial 
capillary hemangiomas. 
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Case Report 
In 2001, at the age of 39 years, the female patient had been diagnosed with an IgA lambda-
plasmacytoma. Further, severe mixed axonal and demyelinating sensomotor polyneuropathy, 
essential thrombocythemia and multiple allergies had been found. The plasmacytoma had 
been treated with four cycles of idarubicine and dexamethasone, cyclophosphamide and stem 
cell apheresis, and in 2002, high-dose melphalan and subsequent peripheral blood stem cell 
transplantation. A very good partial response only with monoclonal IgA lambda detected by 
immunofixation had been noted. Concerning the patient’s polyneuropathy, a considerable 
clinical benefit, but no substantial electrophysiological improvement had been observed. 
Controls at regular intervals had shown stable parameters to date. 
In 2007, the patient presented herself to a neurologist with transient diplopia. At that time, 
neurological examination showed the known signs of distally and right accentuated 
polyneuropathy with grade 3-4/5 lower extremity paraparesis and hypaesthesia without any 
new symptoms. In particular, no pathologic nystagmus, no ocular muscle paresis and no 
meningism were detected. The presence of headache was negated. Neither fundoscopy nor 
measurement of cerebrospinal fluid pressure was performed at that time. An MRI scan 
revealed three intracranial contrast-enhancing lesions. A tumor close to the dura was resected; 
histology showed a capillary hemangioma similar to the patient’s skin hemangiomas which 
had been noticed and partially removed around that time. There was no evidence of von 
Hippel-Lindau disease; the family history was unremarkable. Due to benign histology and a 
lack of clinical symptoms that could be attributed to these lesions, a conservative approach 
with regular follow-up was taken (Fig. 1A-C). 
Nine months later, the patient was admitted to our department with headache, defects of the 
visual field and blurred vision. Papilledema with reduced visual acuity on both eyes was 
detected. MRI showed the intracranial hemangiomas unchanged, a venous sinus thrombosis 
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was excluded. Lumbar puncture revealed an elevated opening pressure of over 50 cm H2O 
with increased protein (7.1 g/l). Since no improvement was observed in spite of frequent 
lumbar puncture and treatment with acetazolamide, a ventriculoperitoneal shunt was placed: 
pressure normalized and papilledema regressed with normalized bilateral visual acuity. Serum 
– but not cerebrospinal fluid – VEGF levels were elevated in our patient compared to control 
patients presenting with polyneuropathy (Fig. 1D). 
Three months later, the patient developed simple partial seizures; MRI revealed a slight 
increase in volume of the left parietal lesion. The neoplasm was resected and histopathological 
examination showed a capillary hemangioma with focal glomeruloid features (Fig. 2A,B). 
Presence of human herpesvirus-8 (HHV-8) DNA in tumor tissue – an association of HHV-8 
with POEMS syndrome had previously been suggested [7] – was ruled out. The third tumor, 
again a capillary hemangioma displaying few eosinophilic globules which were periodic acid-
Schiff (PAS)-positive and showed kappa and lambda light chain deposits (Fig. 2C,D), was 
removed three months later. Immunochemical staining revealed deposition of IgM, IgA and 
IgG. 
 
Discussion 
We diagnosed POEMS syndrome in this female patient with polyneuropathy, IgA lambda-
plasmacytoma, thrombocytosis, hepatomegaly, papilledema with elevated protein levels in 
cerebrospinal fluid and multiple cutaneous and intracranial hemangiomas. The good response 
of polyneuropathy to immunosuppressive therapy in the patient’s past medical history is in 
line with this diagnosis. Capillary hemangiomas are benign vascular neoplasms that may grow 
rapidly but also often undergo spontaneous regression within few years [17]. Those affecting 
the central nervous system (CNS) mostly are primary lesions of the bone secondarily 
impinging upon the CNS [10]. So far, intracranial hemangiomas have not been reported in 
patients with POEMS syndrome [1]. Although a coincidence of two rare diseases cannot be 
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excluded, a relation between cutaneous and intracranial lesions seems probable. All skin 
lesions and two of the intracranial tumors were capillary hemangiomas; one intracranial 
hemangioma displayed partially capillary, partially glomeruloid features. The cytoplasmic 
eosinophilic globules of glomeruloid hemangiomas correspond to polytypic immunoglobulin 
[17]. In line with these observations, immunochemical staining did not show clonal 
immunoglobulin deposits in our case. Albeit reported in few other patients [6, 15], 
glomeruloid hemangiomas are considered POEMS-specific [3, 14]. Usually, those 
hemangiomas are limited to the skin. Recently, a patient with POEMS syndrome with 
multiple mucosal hemangiomas of the small bowel and colon was described [8]. However, the 
reason for developing intracranial hemangiomas in this patient remains unclear. One possible 
explanation could be an innate vulnerability of structures of ectodermal origin to VEGF. 
Symptoms of intracranial hypertension (headache, visual symptoms, papilledema) with 
elevated opening pressure and increased cerebrospinal fluid protein sometimes appear in 
patients with POEMS syndrome for unknown reason. However, such severe intracranial 
hypertension requiring ventriculoperitoneal shunting, as found in our patient, is not common 
in POEMS syndrome. There is no evidence that there is any association of these symptoms 
with the intracranial hemangiomas. 
Although the pathogenesis of POEMS syndrome is complex and unclear, VEGF appears to be 
an essential cytokine in this multi-system disease. Serum VEGF elevation in patients with 
POEMS syndrome and a correlation with the activity of the disease has been reported [12, 16]. 
Compared to our patient’s situation before chemotherapy with peripheral blood stem cell 
transplantation, when she was wheelchair-bound because of her neuropathy, her general 
condition had clearly improved. Nevertheless, a still elevated VEGF suggests an active 
disease, also reflected by the appearance of hemangiomas and intracranial hypertension. In 
consideration of different clinical reports focussing on experimental therapeutic strategies 
such as anti-VEGF antibodies (bevacizumab, with contradictory results, [2, 11, 13]), further 
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investigation concerning the role of VEGF in this complex disease is needed and will provide 
valuable information towards a better understanding of its pathophysiology. 
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Figure legends 
Figure 1. (A) T1-weighted axial MRI showed a strongly enhancing, extraaxial tumor in the 
medial part of the left temporal lobe with broad attachment to the tentorial notch. (B) 
Another extraaxial, equally enhancing tumor was present on the convexity in the dorsal part 
of the left temporal lobe (T1-weighted MRI after contrast administration). (C) Contrast-
enhanced, T1-weighted MRI in coronal plane demonstrated the broad attachment of the 
temporo-dorsal tumor to the dura and showed a thickening and pathological contrast 
enhancement of the dura and the subdural space of the left hemisphere.(D) Serum VEGF 
levels were increased in the POEMS patient – before (05/2001) and five years after (12/2007) 
chemotherapy with peripheral blood stem cell transplantation – compared to five control 
patients who were admitted to hospital for classification of polyneuropathy. For the 
determination of VEGF, a Quantikine Human VEGF ELISA Kit was used (R&D Systems, 
Minneapolis, MN). 
 
Figure 2. (A) Hematoxylin-eosin staining displaying glomeruloid inclusions in the 
hemangioma of the left parietal lobe. (B) CD34-immunostaining demonstrating numerous 
capillaries in the tumor. The PAS-positive eosinophilic globules showed kappa (C) and 
lambda (D) light chain deposits. Scale bar, 100µm. 
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